The DOI matches its Crossref record; 373 of the 373 references it cites were found in a registry or an index.
Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics
Abstract
Recent times have witnessed an upsurge in the incidence of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and amyotrophic lateral sclerosis. The treatment of the same remains a daunting challenge due to the limited access of therapeutic moieties across the blood–brain barrier. Engineered nanoparticles with a size less than 100 nm provide multifunctional abilities for solving these biomedical and pharmacological issues due to their unique physico‐chemical properties along with capability to cross the blood–brain barrier. Needless to mention, there is a scarcity of review articles summarizing recent developments of various nanomaterials including liposomes, polymeric nanoparticles, metal nanoparticles, and bio‐nanoparticles toward the therapeutic and theranostics applications for various neurodegenerative disorders. Here, a broad spectrum of nanomedicinal approaches to eradicate neurodegenerative disorders is provided, along with a brief account of neuroprotection and neuronal tissue regeneration, current clinical status, issues related to safety, toxicity, challenges, and future outlook.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using nanocarriers like liposomes, nanoparticles, and micelles, radiopharmaceuticals can be protected, ensuring their delicate contents remain intact, while also offering improved compatibility and extended circulation within the body [63].”
From Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation (2024) · cites this paper as [63]
In the citing paper
“Owing to their unique physicochemical properties and inherent ability to penetrate the BBB, engineered NPs with dimensions below 100 nm show considerable promise in addressing a range of biological and pharmacological challenges [65].”
From Targeted Nanoparticles for Drug Delivery Across the Blood–Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review (2026) · cites this paper as [65]
Citations
Cites
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
ILAE official report: a practical clinical definition of epilepsy
Fisher, R. S., Acevedo, C., Arzimanoglou, A., Bogacz, A., Cross, J. H., Elger, C. E., Engel, J., Forsgren, L., French, J. A., Glynn, M., et al. (2014) · Epilepsia · doi:10.1111/epi.12550 · Cited by 6,108
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.13 · Cited by 5,415
Uttara, B., Singh, A., Zamboni, P., & Mahajan, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602823 · Cited by 3,378
Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946
Self-citationPericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
Research works printed but not linked: 13
- Birks J. S., 2018, Cochrane Database Syst. Rev., 6, CD001190
- Carlesi C., 2011, Arch. Ital. Biol., 149, 151
- Chen W., 2018, Adv. Mater., 30
- Fu T., 2016, Neural Plast., 2016, 1
- Wang Y. L., 2018, Zhonghua Yixue Zazhi, 98, 2678
- Cummings J., 2017, J. Prev. Alzheimers Dis., 4, 109
- Hickey P., 2011, Drug Des., Dev. Ther., 5, 241
- Fernandez H. H., 2016, npj Parkinson's Dis., 2, 1
- 10.1002/adma.201801362 · DOI · Paper page
- Shin J. W., 2016, Hum. Mol. Genet., 25, 4566
- Sone D., 2019, Mol. Psychiatry
- Yusuf M., 2012, Int. J. Nanomed., 7, 4311
- Carpenter D. O., 2001, Int. J. Occup. Med. Environ. Health, 14, 209
Cited by
Lung cancer immunotherapy: progress, pitfalls, and promises
Lahiri, A., Maji, A., Potdar, P. D., Singh, N., Parikh, P., Bisht, B., Mukherjee, A., & Paul, M. K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01740-y · Cited by 1,102
Self-citationOuyang, J., Xie, A., Zhou, J., Liu, R., Wang, L., Liu, H., Kong, N., & Tao, W. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01148k · Cited by 385
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation
Dhoundiyal, S., Srivastava, S., Kumar, S., Singh, G., Ashique, S., Pal, R., Mishra, N., & Taghizadeh-Hesary, F. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01627-0 · Cited by 144
“Using nano-carriers like liposomes, nanoparticles, and micelles, radiopharmaceuticals can be protected, ensuring their delicate contents remain intact, while also offering improved compatibility and extended circulation within the body [63].”
BackgroundLa Barbera, L., Mauri, E., D’Amelio, M., & Gori, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.939855 · Cited by 74
Moorthy, H., & Govindaraju, T. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01319 · Cited by 64
Metadata
- Authors
- Mukherjee, S., Madamsetty, V. S., Bhattacharya, D., Roy Chowdhury, S., Paul, M. K., & Mukherjee, A.
- Affiliations
- Rice University (US)
- Mayo Clinic (US)
- Birla Institute of Technology and Science, Pilani (IN)
- Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center 986025 Nebraska Medical Center Omaha NE 68198‐6025 USA
- University of California, Los Angeles (US)
- Aavishkar Oral Strips Pvt. Ltd. 109/3, IDA, Phase 2, Sector 2, Lane 6, Cherlapally Hyderabad Telangana 500051 India
- Corresponding author
- Mukherjee, Sudip
- Paul, Manash Kumar
- Mukherjee, Anubhab
- Venue
- Advanced Functional Materials
- Publisher
- Wiley
- Published
- 2020-06-16
- Volume
- 30
- Issue
- 35
- ISSN
- 1616-301X (ISSN-L)
- 1616-3028
- OpenAlex
- W3036302963
- Cited by
- 152
- References
- 373
- Citations by year
- 2026: 12 · 2025: 32 · 2024: 29 · 2023: 24 · 2022: 29 · 2021: 22 · 2020: 4
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Functional Materials (publishedVersion)
- Funders
- Rice University
- University of California, Los Angeles
- Mayo Clinic
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- nanomedicine, neurodegenerative diseases, theranostics, blood-brain barrier, engineered nanoparticles, liposomes, polymeric nanoparticles, metal nanoparticles, bionanoparticles, Alzheimer's disease, Parkinson's disease, Huntington's disease, prion disease, amyotrophic lateral sclerosis, neuroprotection, nanoparticle toxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics. https://app.cochat.ai/papers/10.1002/adfm.202003054
- The paper
- Mukherjee, S., Madamsetty, V. S., Bhattacharya, D., Roy Chowdhury, S., Paul, M. K., & Mukherjee, A. (2020). Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics. Advanced Functional Materials. https://doi.org/10.1002/adfm.202003054
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.